IL-6 inhibitors significantly reduced the hazard ratio for relapse as well as the annualized relapse rate of the disease compared to placebo or traditional immunosuppressants. Interleukin (IL)-6 ...

Patients taking apixaban had a similar risk of major and minor bleeding events as those receiving standard of care therapy. SAN DIEGO—Apixaban therapy resulted in a low risk of venous thromboembolism ...

In high-risk pregnancies, patients must commit to antenatal follow-ups as planned so that timely interventions can be introduced, especially in the case of HDFN. A severe case of hemolytic disease of ...

A case of neuromyelitis optica spectrum disorder triggered by a herpes zoster infection was recently published in the Journal of International Medical Research. “The exact etiology of NMOSD remains ...

It is crucial to diagnose seropositive patients early on and provide prompt treatment to prevent attacks and deficits. Serum antibodies for myelin oligodendrocyte glycoprotein (MOG) were more ...

The risk of infection should be carefully weighed before therapies are prescribed in AAV. Therapies used in the management of antineutrophil cytoplasmic (ANCA)-associated vasculitis (AAV) should take ...

The persistence of a high ANCA titer and other symptoms despite a lack of extracapillary proliferations on kidney biopsy led to a diagnosis of AAV. A new case has been reported of a patient with ...

Intravenous immunoglobulins were started earlier in patients whose disease remained monotruncular compared to those who progressed to multitruncular worsening. Eleven percent of focal or multifocal ...

The first oral liquid form of imatinib offers a more patient-friendly option for certain cancers, including aggressive SM. This new solution addresses longstanding challenges in treatment by providing ...

Of the 3 approaches used to detect KIT mutations, pyrosequencing of genomic DNA was the least sensitive. A new study has investigated the feasibility and sensitivity of mRNA/cDNA analysis instead of ...

Chemoimmunotherapy was associated in a study with higher odds of other cancers in patients with CLL or SLL. The adjusted odds of other cancers among those receiving targeted therapies and monoclonal ...

My thanks to my neighborhood supermarket and other stores that still have real people at some of their check-out aisles. It’s a lot easier for folks like me, who have a handicap like multiple ...